Skip to Content

Join the 'Efavirenz' group to help and get support from people like you.

Efavirenz News

CDC: Black Americans With HIV Still Less Likely to Get Ongoing Medical Care

Posted 10 hours ago by Drugs.com

FRIDAY, Feb. 5, 2016 – While HIV diagnoses dropped significantly over the past decade in the United States, blacks with HIV are less likely than whites or Hispanics to receive routine, ongoing care, according to the U.S. Centers for Disease Control and Prevention. From 2005 to 2014, annual HIV diagnoses fell 19 percent in the United States. Infections among black women dropped 42 percent during this period. Despite this progress in the fight against HIV, racial disparities persist, the CDC found. While black people make up 12 percent of the U.S. population, they accounted for nearly half of all HIV diagnoses in 2014. "CDC has been working for many years to eliminate the HIV disparities that exist within the black community," Dr. Eugene McCray, director of the CDC's Division of HIV/AIDS Prevention, said in an agency news release. "While we are seeing signs of success, we must continue ... Read more

Related support groups: Harvoni, HIV Infection, Tamiflu, Atripla, Incivek, Pre-Exposure Prophylaxis, Truvada, Baraclude, Triumeq, Stribild, Complera, Victrelis, Oseltamivir, Tenofovir, Kaletra, Viread, Entecavir, Norvir, Telaprevir, Nevirapine

HIV Can Persist in Body Despite Drug Therapy

Posted 9 days ago by Drugs.com

WEDNESDAY, Jan. 27, 2016 – Even when blood tests of HIV patients on antiretroviral drugs show no sign of the AIDS-causing virus, it can still be replicating in lymphoid tissue, researchers report. The study offers important new insight into how HIV persists in the body despite treatment with the powerful drugs, according to the team of international researchers led by Northwestern University's Feinberg School of Medicine in Chicago. To reach their finding, they examined viral sequences in samples of lymph node and blood cells from three HIV-infected patients who had no detectable virus in their blood. And what they found was that a viral reservoir in lymphoid tissue, which scientists believed held long-lived infected cells in a resting state, was being constantly replenished with infected cells. "The challenge is to deliver drugs at clinically effective concentrations to where the ... Read more

Related support groups: Harvoni, HIV Infection, Atripla, Sovaldi, Incivek, Pre-Exposure Prophylaxis, Truvada, Baraclude, Stribild, Triumeq, Victrelis, Complera, Sofosbuvir, Tenofovir, Viread, Kaletra, Entecavir, Norvir, Diagnosis and Investigation, Telaprevir

New HIV Treatment Shows Promise in Early Research

Posted 23 Dec 2015 by Drugs.com

WEDNESDAY, Dec. 23, 2015 – Preliminary new research raises the prospect that a recently discovered antibody – an important component of the immune system – could be enlisted to boost the body's response to HIV, the virus that causes AIDS. A single injection of the antibody, currently dubbed VRC01, dramatically reduced the level of HIV in the blood of people who hadn't yet been given antiretroviral drug treatment (ART). ART is the current standard treatment for managing HIV infections, according to the study's authors from the Vaccine Research Center at the National Institute of Allergy and Infectious Diseases in Bethesda, Md. But in people who'd already been treated with ART, the antibody injection had no effect on HIV levels, presumably because the ART therapy had already reduced the levels of HIV virus in their blood, the researchers said. And the researchers were quick to note ... Read more

Related support groups: HIV Infection, Valtrex, Acyclovir, Tamiflu, Ribavirin, Valacyclovir, Incivek, Pre-Exposure Prophylaxis, Zovirax, Baraclude, Victrelis, Famciclovir, Famvir, Oseltamivir, Viread, Kaletra, Tenofovir, Entecavir, Copegus, Valcyte

FDA Lifts Ban on Blood Donations by Gay Men

Posted 21 Dec 2015 by Drugs.com

MONDAY, Dec. 21, 2015 – Gay and bisexual men who have abstained from sex for one year will now be allowed to donate blood in the United States. The new policy, announced Monday by the U.S. Food and Drug Administration, reverses a three-decades-old ban on donations from this group of men that traces back to the start of the AIDS epidemic. "The FDA's responsibility is to maintain a high level of blood product safety for people whose lives depend on it," FDA Acting Commissioner Stephen Ostroff said in an agency news release. "We have taken great care to ensure this policy revision is backed by sound science and continues to protect our blood supply." The FDA said it was changing its policy based on data from other countries that show allowing such donations would not increase the risk of HIV-tainted blood entering America's blood supply. FDA officials have estimated that about half of the ... Read more

Related support groups: Blood Disorders, Bleeding Disorder, Harvoni, HIV Infection, Valtrex, Anemia, Acyclovir, Tamiflu, Atripla, Ribavirin, Valacyclovir, Incivek, Pre-Exposure Prophylaxis, Zovirax, Blood Transfusion, Truvada, Triumeq, Baraclude, Stribild, Complera

Risky Sexual Behaviors Put Many Young Gay Men at Risk of HIV: Study

Posted 7 Dec 2015 by Drugs.com

MONDAY, Dec. 7, 2015 – Young American gay and bisexual men who have detectable blood levels of HIV – the virus that causes AIDS – are also more likely to engage in risky sexual behavior that might spread the virus, a new study has found. "While many of these young men are engaged in care, and success stories are many, we still have work to do to reduce the rate of new infections," study author Patrick Wilson, an assistant professor of sociomedical sciences at Columbia University's Mailman School of Public Health in New York City, said in a university news release. Different strategies to help prevent HIV infections and promote safe sex are needed for this group, his team wrote in the Dec. 7 issue of the journal JAMA Pediatrics. According to the researchers, young men between the ages of 13 and 29 who are gay or bisexual are particularly vulnerable to infection with HIV and now ... Read more

Related support groups: Birth Control, Contraception, Emergency Contraception, Harvoni, HIV Infection, Postcoital Contraception, Atripla, Incivek, Pre-Exposure Prophylaxis, Truvada, Triumeq, Stribild, Baraclude, Victrelis, Complera, Tenofovir, Kaletra, Viread, Entecavir, Norvir

HIV Rates Fall, But Not All Groups Benefit, U.S. Study Finds

Posted 7 Dec 2015 by Drugs.com

MONDAY, Dec. 7, 2015 – The number of Americans diagnosed with HIV each year declined by about one-fifth during the past decade, but not all groups saw drops in prevalence, a federal government study shows. Between 2005 and 2014, the overall annual number of HIV diagnoses fell 19 percent – from nearly 48,800 to just over 39,700 a year. The drop was led by a 63 percent decline among injection drug users, a 42 percent drop among black women, and a 35 percent decrease among heterosexuals. However, annual HIV diagnoses among gay and bisexual men actually rose about 6 percent during the study period, from about 25,000 to just over 26,600 a year, although they recently stabilized at less than a 1 percent increase a year. The increase in HIV diagnoses among gay and bisexual men was driven largely by blacks and Hispanics, the U.S. Centers for Disease Control and Prevention report found. HIV ... Read more

Related support groups: Harvoni, HIV Infection, Atripla, Incivek, Truvada, Baraclude, Stribild, Triumeq, Complera, Victrelis, Kaletra, Viread, Tenofovir, Entecavir, Norvir, Telaprevir, Diagnosis and Investigation, Reyataz, Lamivudine, Boceprevir

Charlie Sheen: I'm HIV-Positive

Posted 17 Nov 2015 by Drugs.com

TUESDAY, Nov. 17, 2015 – Actor Charlie Sheen acknowledged Tuesday that he is infected with HIV, the virus that causes AIDS. "It's a hard three letters to absorb. It's a turning point in one's life," Sheen, who is 50, said during an interview on NBC's Today show with co-host Matt Lauer. Sheen said he was diagnosed about four years ago and was going public now for two reasons: to end an extortion campaign that he claimed has cost him millions of dollars and to help combat the stigma of HIV. "I have to put a stop to this onslaught, this barrage of attacks and of sub-truths and very harmful and mercurial stories that are about me, threatening the health of so many others that couldn't be further from the truth," he said of the extortion efforts. Sheen said he initially shared the diagnosis with people he thought he could trust, but has since paid out roughly $10 million to keep his ... Read more

Related support groups: HIV Infection, Incivek, Pre-Exposure Prophylaxis, Baraclude, Victrelis, Kaletra, Viread, Tenofovir, Norvir, Entecavir, Telaprevir, Nevirapine, Lamivudine, Boceprevir, Reyataz, Hepsera, Abacavir, Prezista, Tivicay, Olysio

Reports Say Charlie Sheen HIV-Positive

Posted 16 Nov 2015 by Drugs.com

MONDAY, Nov. 16, 2015 – Actor Charlie Sheen is reportedly HIV-positive and will discuss the diagnosis Tuesday morning on NBC's Today show, according to multiple published reports. People magazine reported Monday afternoon that individuals close to Sheen approached Hollywood publicist and crisis manager Howard Bragman six months ago on ways to deal with the matter, but Bragman said he never dealt directly with Sheen. "The interview could open up a lot of sympathy for him, but he has to be concerned about a fear of litigation from former sexual partners. You don't take that lightly," Bragman told the magazine. He added that the 50-year-old Sheen "is getting treatment, and a lot of people in his life know about it." Sheen has a history of substance abuse and has admitted to soliciting prostitutes in the past, People reported. "It's been going on for quite a while. He's not necessarily ... Read more

Related support groups: HIV Infection, Incivek, Pre-Exposure Prophylaxis, Baraclude, Victrelis, Kaletra, Viread, Tenofovir, Norvir, Entecavir, Telaprevir, Nevirapine, Lamivudine, Boceprevir, Reyataz, Hepsera, Abacavir, Prezista, Tivicay, Olysio

HIV Therapy May Also Lower Risk for Hepatitis B, Study Says

Posted 12 Oct 2015 by Drugs.com

MONDAY, Oct. 12, 2015 – Not only does effective HIV therapy thwart the AIDS-causing virus, it may also reduce the risk for hepatitis B infection, a new study says. "What this means to us is that effective HIV therapy appears to restore an impairment in the immune response that protects someone with HIV from acquiring hepatitis B infection," study senior author Dr. Chloe Thio, a professor of medicine at Johns Hopkins University School of Medicine, said in a university news release. The study, published in the October issue of Annals of Internal Medicine, involved 2,400 gay and bisexual men who were enrolled in the Multicenter AIDS Cohort Study. Researchers found that the men successfully treated with HIV therapy had the same risk for hepatitis B infection as the men who did not have HIV. Hepatitis B is a virus that can damage the liver. The study showed HIV-positive men on HIV therapy ... Read more

Related support groups: Harvoni, HIV Infection, Valtrex, Acyclovir, Atripla, Hepatitis B, Sovaldi, Ribavirin, Valacyclovir, Incivek, Pre-Exposure Prophylaxis, Zovirax, Truvada, Pegasys, Baraclude, Triumeq, Stribild, Victrelis, Complera, Famciclovir

Almost Half of American Adults With HIV Don't Take Meds: Report

Posted 24 Sep 2015 by Drugs.com

THURSDAY, Sept. 24, 2015 – Almost half of American adults infected with HIV don't take medications that can prevent them from developing AIDS, a new government report shows. The statistics, based on data gathered from 2007 to 2012, are a few years out of date, so it's not clear whether the situation has changed. Still, the report – an analysis of people aged 18 to 59 – suggests a widespread lack of recommended care. "Based on what we know nowadays, everyone who's HIV-positive should be on therapy," said Dr. Carlos del Rio, co-director of the Center for AIDS Research at Emory University, in Atlanta. "This highlights the challenges we have ahead because we have such an unequal epidemic." The report, authored by Dr. Joseph Woodring of the U.S. National Center for Health Statistics, estimated the prevalence of HIV infection based on a survey of more than 10,000 people. The survey found ... Read more

Related support groups: HIV Infection, Tamiflu, Sovaldi, Incivek, Pre-Exposure Prophylaxis, Baraclude, Victrelis, Sofosbuvir, Oseltamivir, Kaletra, Viread, Tenofovir, Entecavir, Norvir, Telaprevir, Boceprevir, Lamivudine, Reyataz, Nevirapine, Hepsera

HIV Cells Keep Duplicating Even When Treatments Are Working: Study

Posted 6 Aug 2015 by Drugs.com

THURSDAY, Aug. 6, 2015 – HIV can continue to multiply in patients who are responding well to antiretroviral therapy, U.K. researchers say. Treatment advances over the last 30 years mean that HIV – the virus that causes AIDS – is suppressed to almost undetectable levels in many patients, and they can live a long and healthy life. It was believed that after many years of successful therapy, a patient's body would naturally rid itself of HIV. "This research shows that sadly, the HIV virus has found yet another way to escape our treatments," study leader Anna Maria Geretti, a professor from the University of Liverpool in the United Kingdom, said in a university news release. During treatment, the virus tries to avoid destruction by hiding in blood cells that trigger an immune response. HIV does this by integrating its own genetic information into the DNA of immune system cells called CD4 ... Read more

Related support groups: HIV Infection, Incivek, Pre-Exposure Prophylaxis, Baraclude, Victrelis, Kaletra, Tenofovir, Viread, Norvir, Entecavir, Diagnosis and Investigation, Telaprevir, Lamivudine, Boceprevir, Nevirapine, Reyataz, Olysio, Hepsera, Prezista, Epivir

Many U.S. AIDS Patients Still Die When 'Opportunistic' Infections Strike

Posted 1 Jul 2015 by Drugs.com

WEDNESDAY, July 1, 2015 – Even after the advent of powerful medications for suppressing HIV, a new study finds that more than one-third of people in San Francisco who were diagnosed with an AIDS-related infection died within five years. "The main cause of mortality arises from people stopping treatment entirely," said Dr. Robert Grant, a professor at the University of California, San Francisco, who reviewed the findings but was not involved in the research. When HIV treatment lapses, so-called "opportunistic" infections and illnesses can arise, posing a real threat to patients' health, he explained. The bottom line, according to Grant, is that there is still "a long way to go" in prolonging the lives of Americans with HIV/AIDS. The new study was led by Dr. Sandra Schwarcz, associate professor of epidemiology and biostatistics at the University of California, San Francisco. She and her ... Read more

Related support groups: Harvoni, HIV Infection, Tamiflu, Atripla, Sovaldi, Incivek, Pre-Exposure Prophylaxis, Truvada, Baraclude, Stribild, Triumeq, Victrelis, Complera, Mycobacterium avium-intracellulare, Mycobacterium avium-intracellulare - Treatment, Sofosbuvir, Oseltamivir, Viread, Tenofovir, Kaletra

Sequence of Shots May Lead to Effective HIV Vaccine, Mouse Study Finds

Posted 25 Jun 2015 by Drugs.com

THURSDAY, June 25, 2015 – It's unlikely that a single vaccine would ever enable the body to neutralize the HIV virus, but a sequence of immunizations might hold the key, a new mouse study suggests. The immune system could be guided in a series of steps to develop a special type of HIV-fighting antibody, a team of researchers said. Each immunization would be customized for specific stages of the immune system's response to the virus. In the end, the series of shots would result in the production of broadly neutralizing antibodies capable of fighting HIV, the authors said. "As HIV mutates in a patient, the immune system continually adapts. In some patients, this process produces broadly neutralizing antibodies, which are unusual antibodies that can bind to and neutralize a wide range of globally occurring HIV variants. These are the antibodies we want to try to elicit with a vaccine," ... Read more

Related support groups: Harvoni, HIV Infection, Atripla, Sovaldi, Incivek, Pre-Exposure Prophylaxis, Truvada, Baraclude, Stribild, Triumeq, Complera, Victrelis, Sofosbuvir, Tenofovir, Kaletra, Viread, Entecavir, Norvir, Telaprevir, Reyataz

1 in 5 Younger Americans Tested for HIV

Posted 2 Jun 2015 by Drugs.com

TUESDAY, June 2, 2015 – Nearly one-fifth of teens and younger adults in the United States have been tested recently for HIV, federal health officials reported Tuesday. In 2011, more than 1 million Americans 13 and older had HIV, but one in seven did not know their infection status. Routine, voluntary testing is known to reduce transmission of HIV, the virus that causes AIDS, according to the U.S. Centers for Disease Control and Prevention. Researchers at the CDC's National Center for Health Statistics analyzed data from 5,600 females and more than 4,800 males, ages 15-44, who took part in the 2011-2013 National Survey of Family Growth. The researchers found that 19 percent had undergone HIV testing in the past year, an increase from 17 percent in both 2002 and 2006-2010. HIV testing rates in 2011-2013 were 22 percent for females and 16 percent for males, compared with 20 percent for ... Read more

Related support groups: Harvoni, HIV Infection, Atripla, Incivek, Pre-Exposure Prophylaxis, Truvada, Triumeq, Baraclude, Stribild, Complera, Victrelis, Kaletra, Viread, Tenofovir, Entecavir, Norvir, Telaprevir, Diagnosis and Investigation, Reyataz, Lamivudine

Global Trial Finds HIV Drugs Should Be Taken Right After Diagnosis

Posted 28 May 2015 by Drugs.com

WEDNESDAY, May 27, 2015 – People with HIV should start taking medications to battle the virus that causes AIDS as soon as they're diagnosed, a new international study finds. Scientists involved in the trial were so impressed by the health benefits of early use of HIV drugs that they shut the study down early so they could offer the medications to all participants. The findings could alter World Health Organization guidelines about the best way to treat people with HIV, experts said. Currently, WHO recommends that HIV patients not start treatment until their immune system show signs of weakening. "We now have clear-cut proof that it is of significantly greater health benefit to an HIV-infected person to start antiretroviral therapy sooner rather than later," Dr. Anthony Fauci, director of the U.S. National Institute of Allergy and Infectious Diseases, said in a statement. "Moreover, ... Read more

Related support groups: Harvoni, HIV Infection, Tamiflu, Atripla, Incivek, Truvada, Triumeq, Baraclude, Stribild, Complera, Victrelis, Oseltamivir, Tenofovir, Kaletra, Viread, Entecavir, Norvir, Telaprevir, Nevirapine, Ledipasvir/sofosbuvir

Page 1 2 Next

Ask a Question

Further Information

Related Condition Support Groups

HIV Infection, Occupational Exposure, Nonoccupational Exposure

Related Drug Support Groups

Sustiva

Efavirenz Patient Information at Drugs.com